Cargando…
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
DNA amplification seems to be particularly frequent in human breast tumours and has been associated with cancer evolution and aggressiveness. Recent data indicate that new events should be added to the list, such as the amplifications at chromosome 20q13 or the MDM2 gene. The present work aimed at d...
Autores principales: | Courjal, F., Cuny, M., Rodriguez, C., Louason, G., Speiser, P., Katsaros, D., Tanner, M. M., Zeillinger, R., Theillet, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074828/ https://www.ncbi.nlm.nih.gov/pubmed/8980401 |
Ejemplares similares
-
HOXA Amplification Defines a Genetically Distinct Subset of Angiosarcomas
por: Xie, Hongbo M., et al.
Publicado: (2022) -
MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
por: Forschner, Andrea, et al.
Publicado: (2020) -
Amplification and Over-Expression of the MDM2 Gene in Human Soft Tissue Tumours
por: Patterson, Helen, et al.
Publicado: (1997) -
Amplification of the MDM2 gene in human breast cancer and its association with MDM2 and p53 protein status.
por: McCann, A. H., et al.
Publicado: (1995) -
Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma
por: Furgason, John M., et al.
Publicado: (2015)